6505--Glipizide Tablets
Closed Pre-Solicitation Posted
Not the latest version. See the latest pre-solicitation from .
- Solicitation number
- 36E79726R0031
- Agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The VA National Acquisition Center intends to issue RFP 36E79726R0031 for an unrestricted procurement of Glipizide Tablets, with solicitation release anticipated on July 27, 2026 and closing on August 10, 2026. The contract will supply the Department of Veterans Affairs (including Consolidated Mail Order Pharmacies and State Veterans Homes), Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center through the VA's and DoD's respective Pharmaceutical Prime Vendor Programs. One contract will be awarded to a single responsible offeror capable of providing uninterrupted supply. The base contract period is one year plus four pre-priced one-year option periods.
Estimated annual requirements total approximately 414,336 bottles across seven line items: Glipizide 5mg in 90-count (60,691 bottles), 180-count (58,708 bottles), and 500- or 1,000-count options; and Glipizide 10mg in 90-count (26,156 bottles), 180-count (88,612 bottles), 360-count (18,238 bottles), and 500- or 1,000-count options.
Offerors must supply the drug under an exact name matching the label with a unique NDC number; the contractor's label with unique NDC shall be the only label on the product. Unit-of-use packaging requires a minimum 120cc cylindrical bottle with 5.75-inch circumference, safety cap, and label dimensions of 5.25 x 2 inches. The solicitation will be issued in commercial item format under FAR Part 12. All documents will be available electronically at SAM.gov. The contracting office is located in Hines, Illinois; the point of contact is Contract Specialist Deb Fassl at Deborah.Fassl@va.gov or 708-786-5894.
Notice text
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue a Request for Proposal (RFP) 36E79726R0031 for an unrestricted procurement for Glipizide Tablets, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC).
VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DoD s respective Pharmaceutical Prime Vendor Programs.
Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. VA labels must be able to securely adhere over the successful offeror/contractor's label.
This product requires unit of use packaging, as identified in the Schedule of Supplies (e.g., 90, 180, and 360 count bottles). The bottles shall contain a safety-cap capable of having the outer part of the cap deshelled and/or a convertible cap to produce a non-safety cap and a bottle with a minimum required size of 120cc volume. The safety cap must not exceed the diameter of the bottle. The bottle must have a cylindrical body and minimum of 5.75 circumference. The bottle must fit a label with a dimension of 5.25 x 2 . The 0.5 additional space is required to keep the bar code exposed and/or allow for the display of the expiration date and lot number.
Solicitation #36E79726R0031 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about July 27, 2026, with a tentative closing date of August 10, 2026. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at SAM.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Deb Fassl. Questions can be e-mailed to Deborah.Fassl@va.gov.
The estimated annual requirements are as follows:
REQUIREMENT DESCRIPTION
ITEM
DESCRIPTION
UNIT
of
USE
PKG. SIZE
(Tablets
per Bottle)
TOTAL EST. ANNUAL USAGE
(Bottles)
1
GLIPIZIDE 5MG TAB
Y
90
60,691
2
GLIPIZIDE 5MG TAB
Y
180
58,708
3a
GLIPIZIDE 5MG TAB
N
500
50,084
OR
3b
GLIPIZIDE 5MG TAB
N
1000
25,042
4
GLIPIZIDE 10MG TAB
Y
90
26,156
5
GLIPIZIDE 10MG TAB
Y
180
88,612
6
GLIPIZIDE 10MG TAB
Y
360
18,238
7a
GLIPIZIDE 10MG TAB
N
500
57,870
OR
7b
GLIPIZIDE 10MG TAB
N
1000
28,935
Files
| File | Type | Posted |
|---|---|---|
| 36E79726R0031_1.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6505--Glipizide Tablets | Pre-Solicitation | |
| This notice | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6505--Sodium Bicarbonate Injection Vial Restricted to Made in America | National Acquisition Center | No set-aside | |
| 6505--Imatinib Tablets | National Acquisition Center | No set-aside | |
| Methylphenidate ER | Medical Supply Chain | No set-aside | |
| 6505--Department of Veterans Affairs Pharmaceutical Industry Day | Veterans Integrated Service Network 12 | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity